Schmidt-Lanterman's incisures - The principal target of autoimmune attack in demyelinating Guillain-Barre syndrome?

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 58-65

  Görtzen, Angelika ^a   Schlüter, Simone ^a   Veh, Rüdiger W ^b  

^a St Josef Hospital Oberhausen   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoimmunomactivity; Demyelination; Immunocytochemistry; S 100 protein; Screening for autoantibodies

Indexed keywords

ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TRIGEMINAL NERVE;

ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; DEMYELINATING DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; HUMANS; IMMUNOHISTOCHEMISTRY; MYELIN SHEATH; POLYRADICULONEUROPATHY; RATS; RATS, SPRAGUE-DAWLEY; S100 PROTEINS; TRIGEMINAL NERVE;

EID: 0344959519     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00215-X     Document Type: Article

References (20)

1. Boucquey D., Sindic D.J.M., Lamy M., Delmée M., Tomasi J.P., Laterre E.C. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J. Neurol. Sci. 104:1991;56-63.
2. Buchthal F., Carlen F., Behse F. Schmidt-Lanterman clefts: a morphometric study in human sural nerve. Am. J. Anat. 180:1987;156-160.
3. Dalmau, J., Rosenfeld, M.R., 1995. Characterization of neuronal antigens and antineuronal antibodies. In: Phillips, Evans (Eds.), Methods in Neurosciences, Vol. 24; Neuroimmunology. Academic Press, pp. 261-271.
4. Hafer-Macko C., Hsieh S.T., Li C.Y., Ho T.W., Sheikh K., Cornblath D.R., McKhann G.M., Asbury A.K., Griffin J.W. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40:1996;635-644.
5. Hafer-Macko C.E., Sheikh K.A., Li C.Y., Ho T.W., Cornblath D.R., McKhann G.M., Asbury A.K., Griffin J.W. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39:1996;625-635.
6. Hall S.M., Hughes R.A., Atkinson P.F., McColl I., Gale A. Motor nerve biopsy in severe Guillain-Barré syndrome. Ann. Neurol. 31:1992;441-444.
7. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and Treatment of the Guillain-Barré syndrome - Part I. Muscle and Nerve. 18:1995;137-153.
8. Haupt W.F., Rosenow F., van der Ven C., Borberg H., Pawlik G. Sequential treatment of Guillain-Barré syndrome with extracorporal elimination and intravenous immunoglobulin. J. Neurol. Sci. 137:1996;145-149.
9. Jacobs J.M., Scadding J.W. Morphological changes in IgM paraproteinaemic neuropathy. Acta Neuropathol. 80:1990;77-84.
10. Jessen K.R., Mirsky R. Glial fibrillary acidic polypeptides in peripheral glia. Molecular weight, heterogeneity and distribution. J. Neuroimmunol. 8:1985;377-393.
11. Mirsky R., Jessen K.R. The biology of non-myelin-forming Schwann cells. Ann. New York Acad. Sci. 486:1986;132-146.
12. Mithen F.A., Ilyas A.A., Birchem R., Cook S.D. Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons. J. Neurol. Sci. 112:1992;223-232.
13. Parry G.J.G. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle and Nerve. 17:1994;97-99.
14. Quattrini A., Nemni R., Fazio R., Iannaccone S., Lorenzetti I., Grassi F., Canal N. Axonal neuropathy in a patient with monoclonal IgM kappa reactive with Schmidt-Lantermann incisures. J. Neuroimmunol. 33:1991;73-79.
15. Sawant-Mane S., Estep III A., Koski C.L. Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype. J. Neuroimmunol. 49:1994;145-152.
16. Scherer S.S. Molecular specializations at nodes and paranodes in peripheral nerve. Microsc. Res. Techn. 34:1996;452-461.
17. Stoll G., Schwendemann G., Heininger K., Steck A.J., Toyka K.V. Human monoclonal anti-MAG antibody and anti-Leu 7 recognise shared antigenic determinants in peripheral nerve and spinal cord. J. Neurol. Neurosurg. Psychiatry. 48:1985;635-638.
18. Vallat J.M., Leboutet M.J., Jauberteau M.O., Tabaraud F., Couratier P., Akani F. Widenings of the myelin lamellae in a typical Guillain-Barré syndrome. Muscle and Nerve. 17:1994;378-380.
19. The Dutch Guillain-Barré study group, Van der Meché F.G.A., Schmitz P.I.M. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. New England J. Med. 326:1992;1123-1129.
20. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.